Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

12 Dec 2014 15:00

RNS Number : 6804Z
Sopheon PLC
12 December 2014
 

SOPHEON PLC

("Sopheon" or the "Company")

 

TRADING UPDATE

 

Sopheon plc ("Sopheon"), the international provider of software and services that improve the return from innovation and new product development investments, issues a trading update.

 

We have previously highlighted that we expected performance in 2014 to be weighted to the back end of the year, consistent with the fourth quarter of 2013 which was the strongest in our history. Full year revenue visibility today stands at $17.4m compared to $15.0m at the time of the interims. Once again, meeting our commercial goals required a strong finish to the year, and our pipeline included several major license opportunities that would contribute to achieving them. As we approach the end of the year, orders are coming through, and this includes a record number of signatures expected from new customers, expanding our traditionally strong base of existing customers and underpinning future growth potential. However, it now looks increasingly likely that a number of the highest value orders will defer into the first quarter of 2015. As a result, revenue and profits for 2014 will fall below market expectations. As in previous years we will update shareholders on the year's actual performance in January. As we have often stated, the nature of our business makes it difficult to predict exactly when sales will get signed and be recognized. .

 

Since our interim statement, we have continued to push forward with operational and corporate developments. We released version 9.2 of our Accolade solution suite, which we believe provides the most comprehensive resource and portfolio planning and management capabilities in the market. We were delighted to hire Pieter Leijten, a senior business development director formerly at Infor. Pieter has a solid track record of overachievement in enterprise software sales and will lead our commercial team in Europe.

 

Since 2012 Sopheon has implemented a series of actions to improve its corporate profile. These include transferring our Amsterdam listing from Euronext to Alternext; a share consolidation to reduce both the number of shares in issue and the very large number of very small shareholders; a capital restructuring to substantively reduce accumulated losses on the balance sheet; and the securing of new facilities with Silicon Valley Bank. As previously announced, we have faced some challenges. Following our transfer, Euronext announced the closure of Alternext Amsterdam by the end of 2015; the board has not yet concluded on the most appropriate path to address this change. In addition, processing issues in the Netherlands that arose during the original share consolidation procedure led us to initiate a new procedure in recent weeks. The first step, a 500:1 consolidation, was implemented on 18 October and the shareholder meeting for the second step, a 1:500 subdivision, is scheduled for 19 December. Following the first step the directors made a number of share purchases, in Amsterdam, with the intention of providing support for the fractional entitlements that became available, and also underlining the board's continued confidence in the business.

 

A definition of how visibility is calculated was provided in our half- yearly report published on 28 August 2014. 

 

For further information contact:

Barry Mence, Chairman

Sopheon plc

+ 44 (0) 1483 685 735

Arif Karimjee, CFO

Sopheon plc

+ 44 (0) 1483 685 735

Charlotte Stranner / Victoria Bates

finnCap

+ 44 (0) 20 7220 0500

Heather Armstrong

Newgate Threadneedle

+ 44 (0) 20 7653 9842

Claire Verhagen

Citigate First Financial

+ 31 (0) 205 754 010

 

About Sopheon. Sopheon (LSE: SPE) partners with customers to provide complete Enterprise Innovation Performance solutions including software, expertise, and best-practices to achieve exceptional long-term revenue growth and profitability. Sopheon's Accolade® solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle. For the first time, businesses can access a single source of the truth across strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon's solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange, and on the Alternext Exchange in the Netherlands. For more information, please visit www.sopheon.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTZLLFFZLFZFBV
Date   Source Headline
6th Dec 20137:00 amRNSDirector/PDMR Shareholding
5th Dec 20137:00 amRNSCorporate Update
19th Nov 20137:00 amRNSSopheon Delivers Accolade® Release 9.0
7th Nov 20137:00 amRNSInterim Management Statement
11th Sep 20133:00 pmRNSHolding(s) in Company
4th Sep 20133:00 pmRNSHolding(s) in Company
22nd Aug 20137:00 amRNSInterim Results
15th Aug 20133:00 pmRNSHolding(s) in Company
29th Jul 20133:00 pmRNSHolding(s) in Company
26th Jul 20137:00 amRNSTrading Update
15th Jul 20134:15 pmRNSHolding(s) in Company
28th Jun 20133:00 pmRNSTotal Voting Rights
27th Jun 20133:00 pmRNSHolding(s) in Company
19th Jun 20133:42 pmRNSHolding(s) in Company
19th Jun 20137:00 amRNSNew capabilities with Accolade(R) 8.3
14th Jun 20132:00 pmRNSContract Win
12th Jun 201312:00 pmRNSResult of AGM & GM
12th Jun 20137:00 amRNSAGM Statement
4th Jun 20137:00 amRNSIssue of Shares
2nd May 20137:00 amRNSInterim Management Statement
21st Mar 20137:00 amRNSPreliminary Results
30th Jan 20137:00 amRNSTrading Update
23rd Jan 20137:00 amRNSLaunch of Accolade 8.2
7th Dec 201211:36 amPRNHolding(s) in Company
8th Nov 20127:00 amPRNInterim Management Statement
1st Oct 20127:00 amRNSHolding(s) in Company
1st Oct 20127:00 amRNSDirectors' Options
24th Sep 20127:00 amRNSMarket Transfer to NYSE Alternext Concluded
23rd Aug 20127:00 amRNSAmendment to Terms of Convertible Loan Stock
23rd Aug 20127:00 amRNSInterim Results
23rd Jul 20127:00 amRNSTrading Update
13th Jun 20123:14 pmRNSResult of AGM
13th Jun 20127:00 amRNSAGM Statement
15th May 20127:00 amRNSAmendment to terms of Convertible Loan Stock
3rd May 20127:00 amRNSInterim Management Statement
25th Apr 20127:00 amRNSLaunch of Accolade 8.0
22nd Mar 20127:00 amRNSPreliminary Results
16th Feb 20127:00 amRNSTop 10 Solution Provider to CGM
31st Jan 20127:00 amRNSTrading Update
23rd Dec 201112:32 pmRNSExtension of GEM Equity Line
23rd Dec 201112:29 pmRNSTrading Update
5th Dec 201112:40 pmRNSHolding(s) in Company
3rd Nov 20117:00 amRNSInterim Management Statement
25th Aug 20117:00 amRNSInterim Results
25th Jul 20117:00 amRNSTrading Statement
23rd Jun 20112:15 pmRNSDirector/PDMR Shareholding
15th Jun 20117:00 amRNSAGM Statement
5th May 20117:00 amRNSInterim Management Statement
24th Mar 20117:00 amRNSPreliminary Results
10th Feb 20117:00 amPRNAppointment of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.